Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion

Journal of Experimental Medicine

Volumn 183, Issue 2, 1996, Pages 693-698

  Stüber, Eckhard ^a,b   Strober, Warren ^a   Neurath, Markus ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; GLYCOPROTEIN; GLYCOPROTEIN GP 39; HAPTEN; INTERLEUKIN 12; INTERLEUKIN 4; LIGAND; MONOCLONAL ANTIBODY; RECOMBINANT INTERLEUKIN 12; TRINITROBENZENESULFONIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ANTIGEN PRESENTING CELL; ARTICLE; CELL SECRETION; COLITIS; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNOHISTOCHEMISTRY; LAMINA PROPRIA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; CD40 LIGAND; COLITIS; COLON; DISEASE MODELS, ANIMAL; FEMALE; INTERLEUKIN-12; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED STRAINS; PROTEIN BINDING; TH1 CELLS; TRINITROBENZENESULFONIC ACID;

EID: 0030029222     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.183.2.693     Document Type: Article

References (22)

1. + T cells Annu. Rev. Immunol. 12:635-673.
2. Tanaka, T., J. Hu-Li, R.A. Seder, S. De Fazekas, B. Groth, and W.E. Paul. 1993. Interleukin-4 suppresses interleukin-2 and interferon-γ production by naive T cells stimulated by accessory cell-dependent receptor engagement. Proc. Natl. Acad. Sci. USA. 90:5914-5918.
3. + T cells to enhance priming for IFNγ production and diminishes IL-4 inhibition in such priming. Proc. Natl. Acad. Sci. USA. 90:10188-10192.
4. + T cells from αβ-TCR transgenic mice: IL-12 substitution for macrophages to stimulate IFN-γ production is IFN-γ-dependent. Int. Immunol. 5:1119-1128.
5. Kuchroo, V.K., M.P. Das, J.A. Brown, A.M. Ranger, S.S. Zamvil, R.A. Sobel, H.L. Weiner, N. Nabavi, and L.H. Glimcher. 1995. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy. Cell. 80:707-718.
6. Freeman, G.J., V.A. Boussiotis, A. Anumanthan, G.M Bernstein, X.-Y. Ke, P.D. Rennert, G.S. Gray, J.G. Gribben, and L.M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity. 2:523-532.
7. Pfeiffer, C., J. Stein, S. Southwood, H. Ketelaar, A. Sette, and K. Bottomly. 1995. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med 181: 1569-1574.
8. Shu, U., M. Kiniwa, C.Y. Wu, C. Maliszewski, N. Vezzio, J. Hakimi, M. Gately, and G. Delespesse. 1995. Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur. J. Immunol. 25:1125-1128.
9. Neurath, M.F., I. Fuss, B.L. Kelsall, E.R. Scuber, and W. Strober. 1995. Antibodies to IL-12 abrogate established experimental colitis in mice. J. Exp. Med. 182:1281-1290.
10. Noelle, R.J., M. Roy, M. Shepherd, I. Stamenkovic, J.A. Ledbetter, and A. Aruffo. 1992. A 39kD protein on activated helper T cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA. 89: 6550-6554.
11. Van der Heijden, P.J., and W. Stok. 1987. Improved procedure for the isolation of functionally active lymphoid cells from the murine intestine. J. Immunol. Methods. 103:161-167.
12. Morris, G.P., P.L. Beck, M.S. Herridge, W.T. Depew, M.R. Szewzuk, and J.L. Wallace. 1989. Hapten-induced model of colonic inflammation and ulceration in the rat colon. Gastroenterology. 96:795-803.
13. Yamada, T., S. Marshall, R.D. Specian, and M.B. Grisham. 1992. A comparative analysis of two models of colitis in rats. Gastroenterology. 102:1524-1534.
14. Trinchieri, G. 1995. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions chat bridge innate resistance and antigen-specific adaptive immunity. Annu. Rev. Immunol. 13:251-276.
15. Foy, T.M., J.D. Laman, J.A. Ledbetter, A. Aruffo, E. Claasen, and R.J. Noelle. 1994. gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180:157-163.
16. Dune, F.H., R.A. Fava, T.M. Foy, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science (Wash. DC). 261:1328-1330.
17. Dune, F.H., A Aruffo, J.A. Ledbetter, K. Crassi, W.R. Green, L.D. Fast, and R.J. Noelle. 1994. Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-vs-host disease. J. Clin. Invest. 94: 1333-1338.
18. Dune, F.H., T.M. Foy, S.R. Masters, J.D. Laman, and R.J. Noelle. 1994. The role of CD40 in the regulation of humoral and cell-mediated immunity. Immunol. Today. 15:406-411.
19. Foy, T.M., D.M. Shepherd, F.H. Dune, A. Aruffo, J.A. Ledbetter, and R.J. Noelle. 1993. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. Exp. Med. 178:1567-1575.
20. Kennedy, M.K., K.M. Mohler, K.D. Shanebeck, P.R. Baum, K.S. Picha, C.A. Otten-Evans, C.A. Janeway, and K.H. Grabstein. 1994. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol. 24: 116-123.
21. Roy, M., A. Aruffo, J. Ledbetter, P. Linsley, M. Kehry, and R.J. Noelle. 1995. Studies on the interdependence of gp39 and B7 expression and function during antigen-specific immune responses. Eur. J. Immunol. 25:596-603.
22. Kroczek, R.A., D. Graf, D. Brugnoni, S. Giliani, U. Korthäuer, A. Ugazio, G. Senger, H.W. Mages, A. Villa, and L.D. Notarangelo. 1994. Defective expression of CD40-ligand on T cells causes "X-linked immunodeficiency" with hyper-IgM (HIGM1). Immunol. Rev. 138:39-59.